# Institut Claudius Regaud

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/institut-claudius-regaud/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 73 |
| Citations | 481,283 |
| City | Toulouse |
| Country | FR |
| Description | Institut Claudius Regaud is a research organisation in Toulouse, FR. OpenAlex records 5,221 works and 481,283 citations for it. 924 researchers list it as their most recent affiliation. |
| Homepage | http://eng.claudiusregaud.fr/ |
| OpenAlex ID | https://openalex.org/I4210128666 |
| Region | Occitanie |
| Researchers | 924 |
| ROR ID | https://ror.org/03pa87f90 |
| Type | healthcare |
| Works | 5,221 |

## University papers

- [Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma](https://scholariq.org/papers/sunitinib-alone-or-after-nephrectomy-in-metastatic-renal-cell-carcinoma/)
- [Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-placebo-as-post-nephrectomy-adjuvant-therapy-for-clear-cell/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.